Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "DNA synthesis inhibition via cytotoxic damage from ionizing radiation" describes the suppression of replicative DNA synthesis as a result of DNA lesions—predominantly double-strand breaks—caused by ionizing radiation such as X-rays or gamma rays. This leads to activation of cell cycle checkpoints (notably the S-phase checkpoint) in order to halt cell division and allow for attempted DNA repair. If the damage is irreparable or the checkpoint is defective (such as in ataxia-telangiectasia), cells may proceed with damaged DNA, leading to cell death or mutations. This is a key mechanism underlying both the therapeutic efficacy of radiotherapy in cancer and its side effects on normal tissue[3][5][2].
Induction of DNA double-strand breaks (DSBs) and other DNA lesions; Activation of cell cycle checkpoints (especially S-phase checkpoint via ATM/CHK2/CDC25a pathway); Activation of cell death pathways through overwhelming of DNA repair mechanisms[5][6][1]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA synthesis inhibition via cytotoxic damage from ionizing radiation.